Tsuyoshi Mori

743 total citations
42 papers, 551 citations indexed

About

Tsuyoshi Mori is a scholar working on Oncology, Cancer Research and Surgery. According to data from OpenAlex, Tsuyoshi Mori has authored 42 papers receiving a total of 551 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 10 papers in Cancer Research and 8 papers in Surgery. Recurrent topics in Tsuyoshi Mori's work include Cancer Treatment and Pharmacology (9 papers), Breast Cancer Treatment Studies (9 papers) and Breast Lesions and Carcinomas (6 papers). Tsuyoshi Mori is often cited by papers focused on Cancer Treatment and Pharmacology (9 papers), Breast Cancer Treatment Studies (9 papers) and Breast Lesions and Carcinomas (6 papers). Tsuyoshi Mori collaborates with scholars based in Japan, United States and South Korea. Tsuyoshi Mori's co-authors include Tohru Tani, Tomoharu Shimizu, Yuki Kawai, Yoshihiro Endo, Tomoko Umeda, Hiroshi Tsuchihashi, Kazuyoshi Hanasawa, Saraswati Sukumar, Hiroshi Yamamoto and Hiroshi Yamamoto and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Tsuyoshi Mori

37 papers receiving 541 citations

Peers

Tsuyoshi Mori
Dan Pu China
Firas Baidoun United States
Tsuyoshi Mori
Citations per year, relative to Tsuyoshi Mori Tsuyoshi Mori (= 1×) peers Benjamin L. Schlechter

Countries citing papers authored by Tsuyoshi Mori

Since Specialization
Citations

This map shows the geographic impact of Tsuyoshi Mori's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tsuyoshi Mori with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tsuyoshi Mori more than expected).

Fields of papers citing papers by Tsuyoshi Mori

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tsuyoshi Mori. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tsuyoshi Mori. The network helps show where Tsuyoshi Mori may publish in the future.

Co-authorship network of co-authors of Tsuyoshi Mori

This figure shows the co-authorship network connecting the top 25 collaborators of Tsuyoshi Mori. A scholar is included among the top collaborators of Tsuyoshi Mori based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tsuyoshi Mori. Tsuyoshi Mori is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nakayama, Takahisa, Ken‐ichi Mukaisho, Tsuyoshi Mori, et al.. (2018). Progression Potential of Ductal Carcinoma in situ Assessed by Genomic Copy Number Profiling. Pathobiology. 86(2-3). 92–101. 1 indexed citations
2.
Ishida, Mitsuaki, Tomoko Umeda, Yuki Kawai, et al.. (2014). Magnetic resonance imaging shrinkage patterns following neoadjuvant chemotherapy for breast carcinomas with an emphasis on the radiopathological correlations. Molecular and Clinical Oncology. 2(5). 783–788. 15 indexed citations
3.
Abe, Hajime, Tsuyoshi Mori, Yuki Kawai, et al.. (2013). Feasibility Study of Docetaxel and Cyclophosphamide Six- Cycle Therapy as Adjuvant Chemotherapy for Japanese Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer Patients. Asian Pacific Journal of Cancer Prevention. 14(8). 4835–4838. 3 indexed citations
4.
Ishida, Mitsuaki, Tomoko Umeda, Yuki Kawai, et al.. (2013). Mucinous carcinoma occurring in the male breast. Oncology Letters. 7(2). 378–380. 5 indexed citations
5.
Abe, Hajime, Tsuyoshi Mori, Yuki Kawai, et al.. (2013). Safety Assessment of Intravenous Administration of Trastuzumab in 100ml Saline for the Treatment of HER2-Positive Breast Cancer Patients. Asian Pacific Journal of Cancer Prevention. 14(8). 4843–4846. 4 indexed citations
6.
Abe, Hajime, Yuki Kawai, Tsuyoshi Mori, et al.. (2013). The Kampo Medicine Goshajinkigan Prevents Neuropathy in Breast Cancer Patients Treated with Docetaxel. Asian Pacific Journal of Cancer Prevention. 14(11). 6351–6356. 26 indexed citations
7.
Yamamoto, Hiroshi, Kazuhisa Maeda, Hiroshi Tsuchihashi, et al.. (2013). Association between Reduction of Plasma Adiponectin Levels and Risk of Bacterial Infection after Gastric Cancer Surgery. PLoS ONE. 8(3). e56129–e56129. 16 indexed citations
8.
Chun, Yong Soon, Takahiro Yoshida, Tsuyoshi Mori, et al.. (2012). Intraductally administered pegylated liposomal doxorubicin reduces mammary stem cell function in the mammary gland but in the long term, induces malignant tumors. Breast Cancer Research and Treatment. 135(1). 201–208. 20 indexed citations
9.
Abe, Hajime, Yuki Kawai, Tsuyoshi Mori, et al.. (2012). Feasibility of prior administration of cyclophosphamide in TC combination treatment. Breast Cancer. 21(2). 202–207. 1 indexed citations
10.
Abe, Hajime, Tsuyoshi Mori, Yuki Kawai, et al.. (2012). Feasibility and toxicity of docetaxel before or after fluorouracil, epirubicin and cyclophosphamide as adjuvant chemotherapy for early breast cancer. International Journal of Clinical Oncology. 18(3). 487–491. 5 indexed citations
11.
Abe, Hajime, Tsuyoshi Mori, Tomoko Umeda, et al.. (2011). Indocyanine green fluorescence imaging system for sentinel lymph node biopsies in early breast cancer patients. Surgery Today. 41(2). 197–202. 61 indexed citations
12.
Lo, Pang-Kuo, Ji Shin Lee, Xiaohui Liang, et al.. (2010). Epigenetic Inactivation of the Potential Tumor Suppressor Gene FOXF1 in Breast Cancer. Cancer Research. 70(14). 6047–6058. 67 indexed citations
13.
Abe, Hajime, Tomoko Umeda, Yuki Kawai, et al.. (2010). [Adjuvant trastuzumab can be infused safely over 30 minutes].. PubMed. 37(10). 1887–91. 2 indexed citations
14.
Yamamoto, Hiroshi, Hiroshi Tsuchihashi, Tsuyoshi Mori, et al.. (2007). Transient Receptor Potential Vanilloid 1 Antagonist, Capsazepine, Improves Survival in a Rat Hemorrhagic Shock Model. Annals of Surgery. 245(6). 964–970. 20 indexed citations
15.
Tsuchihashi, Hiroshi, Hiroshi Yamamoto, Kazuhisa Maeda, et al.. (2006). Circulating Concentrations of Adiponectin, an Endogenous Lipopolysaccharide Neutralizing Protein, Decrease in Rats with Polymicrobial Sepsis. Journal of Surgical Research. 134(2). 348–353. 55 indexed citations
16.
Mori, Tsuyoshi, Hiroshi Yamamoto, Takahisa Tabata, et al.. (2005). A free radical scavenger, edaravone (MCI-186), diminishes intestinal neutrophil lipid peroxidation and bacterial translocation in a rat hemorrhagic shock model*. Critical Care Medicine. 33(5). 1064–1069. 16 indexed citations
17.
Yamamoto, Hiroshi, et al.. (2005). A Possible Role of GLP-1 in the Pathophysiology of Early Dumping Syndrome. Digestive Diseases and Sciences. 50(12). 2263–2267. 33 indexed citations
18.
Mori, Tsuyoshi, et al.. (2001). Effect of Insulina Leaf Extract on Development of Diabetes. Comparison between Normal, Streptozotocin-induced Diabetic Rats and Hereditary Diabetic Mice.. Nippon Eiyo Shokuryo Gakkaishi. 54(4). 197–203. 12 indexed citations
19.
Yoshida, Ryo, et al.. (1996). A Case of Recklinghausen's Disease Accompanied with Pancreatitis.. The Japanese Journal of Gastroenterological Surgery. 29(5). 1055–1058. 2 indexed citations
20.
Nikaido, Yasuyoshi, Tsuyoshi Mori, Tokio Okusa, et al.. (1994). A Case Report of Esophageal Adenosquamous Carcinoma with Liver Metastasis.. The Japanese Journal of Gastroenterological Surgery. 27(10). 2238–2242. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026